Voyageur Pharmaceuticals (CVE:VM) Hits New 12-Month High – What’s Next?

Voyageur Pharmaceuticals Ltd. (CVE:VM)’s stock price reached a new 52-week high during mid-day trading on Wednesday . The company traded as high as C$0.25 and last traded at C$0.23, with a volume of 270656 shares trading hands. The stock had previously closed at C$0.24.

Voyageur Pharmaceuticals Stock Down 31.3 %

The company has a 50 day moving average of C$0.10 and a 200-day moving average of C$0.07. The company has a debt-to-equity ratio of 3.21, a current ratio of 0.17 and a quick ratio of 0.84. The company has a market cap of C$23.01 million, a P/E ratio of -16.50 and a beta of 0.32.

Voyageur Pharmaceuticals Company Profile

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.